

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcomere organization (GO:0045214) | 7.37976328 |
| 2 | cardiac myofibril assembly (GO:0055003) | 6.58426361 |
| 3 | actin-myosin filament sliding (GO:0033275) | 6.22050234 |
| 4 | muscle filament sliding (GO:0030049) | 6.22050234 |
| 5 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 5.98405306 |
| 6 | myofibril assembly (GO:0030239) | 5.89932169 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 5.75061741 |
| 8 | modulation by symbiont of host defense response (GO:0052031) | 5.75061741 |
| 9 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.75061741 |
| 10 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.75061741 |
| 11 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.75061741 |
| 12 | modulation by symbiont of host immune response (GO:0052553) | 5.75061741 |
| 13 | negative regulation of cell killing (GO:0031342) | 5.57153947 |
| 14 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.57153947 |
| 15 | * plasma membrane repair (GO:0001778) | 5.46458705 |
| 16 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.33356753 |
| 17 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 5.30976201 |
| 18 | actin-mediated cell contraction (GO:0070252) | 5.26042428 |
| 19 | leukocyte migration involved in inflammatory response (GO:0002523) | 5.20325544 |
| 20 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.19812511 |
| 21 | detection of other organism (GO:0098543) | 5.16850771 |
| 22 | regulation of skeletal muscle contraction (GO:0014819) | 5.11738647 |
| 23 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.09487791 |
| 24 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.96219270 |
| 25 | neutrophil activation involved in immune response (GO:0002283) | 4.95012756 |
| 26 | actomyosin structure organization (GO:0031032) | 4.93212191 |
| 27 | cardiac muscle cell development (GO:0055013) | 4.86921652 |
| 28 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.83307720 |
| 29 | detection of molecule of bacterial origin (GO:0032490) | 4.78335028 |
| 30 | detection of bacterium (GO:0016045) | 4.77398758 |
| 31 | cardiac muscle contraction (GO:0060048) | 4.75217709 |
| 32 | vascular endothelial growth factor signaling pathway (GO:0038084) | 4.75149316 |
| 33 | leukocyte aggregation (GO:0070486) | 4.71506998 |
| 34 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.71288717 |
| 35 | macrophage activation involved in immune response (GO:0002281) | 4.69744497 |
| 36 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.64764230 |
| 37 | cardiac cell development (GO:0055006) | 4.61975902 |
| 38 | cellular extravasation (GO:0045123) | 4.61248772 |
| 39 | carnitine shuttle (GO:0006853) | 4.58969444 |
| 40 | heart trabecula formation (GO:0060347) | 4.58662772 |
| 41 | detection of external biotic stimulus (GO:0098581) | 4.57195710 |
| 42 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.50121117 |
| 43 | response to peptidoglycan (GO:0032494) | 4.44754094 |
| 44 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.36258166 |
| 45 | cardiac muscle tissue morphogenesis (GO:0055008) | 4.34340911 |
| 46 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.32791569 |
| 47 | tricarboxylic acid cycle (GO:0006099) | 4.31719745 |
| 48 | regulation of actin filament-based movement (GO:1903115) | 4.29309939 |
| 49 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 4.25768384 |
| 50 | fatty acid transmembrane transport (GO:1902001) | 4.23468680 |
| 51 | actin filament-based movement (GO:0030048) | 4.17886924 |
| 52 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.14468877 |
| 53 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.13514697 |
| 54 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.98707861 |
| 55 | detection of biotic stimulus (GO:0009595) | 3.98570474 |
| 56 | negative regulation of interleukin-12 production (GO:0032695) | 3.96886376 |
| 57 | striated muscle contraction (GO:0006941) | 3.96780356 |
| 58 | muscle tissue morphogenesis (GO:0060415) | 3.96375054 |
| 59 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.96079975 |
| 60 | response to host immune response (GO:0052572) | 3.95682125 |
| 61 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.95682125 |
| 62 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.94625330 |
| 63 | regulation of relaxation of muscle (GO:1901077) | 3.93765558 |
| 64 | neutrophil activation (GO:0042119) | 3.91891871 |
| 65 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.90866315 |
| 66 | macrophage activation (GO:0042116) | 3.87496157 |
| 67 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.86866214 |
| 68 | adult heart development (GO:0007512) | 3.83196113 |
| 69 | respiratory burst (GO:0045730) | 3.79918018 |
| 70 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.78018297 |
| 71 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.74379821 |
| 72 | response to host (GO:0075136) | 3.74379821 |
| 73 | response to host defenses (GO:0052200) | 3.74379821 |
| 74 | microglial cell activation (GO:0001774) | 3.73970674 |
| 75 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.71941851 |
| 76 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.71307918 |
| 77 | cardiac muscle hypertrophy (GO:0003300) | 3.69959403 |
| 78 | regulation of gamma-delta T cell activation (GO:0046643) | 3.68789019 |
| 79 | regulation of striated muscle contraction (GO:0006942) | 3.68365040 |
| 80 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.67522207 |
| 81 | cell communication involved in cardiac conduction (GO:0086065) | 3.63519041 |
| 82 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.60654523 |
| 83 | response to interleukin-15 (GO:0070672) | 3.59459907 |
| 84 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 3.57620699 |
| 85 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.57253847 |
| 86 | neutrophil mediated immunity (GO:0002446) | 3.53608005 |
| 87 | regulation of the force of heart contraction (GO:0002026) | 3.53486540 |
| 88 | granulocyte activation (GO:0036230) | 3.52505233 |
| 89 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.52306463 |
| 90 | striated muscle hypertrophy (GO:0014897) | 3.52238359 |
| 91 | regulation of sarcomere organization (GO:0060297) | 3.48840752 |
| 92 | germinal center formation (GO:0002467) | 3.45279331 |
| 93 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.44007626 |
| 94 | regulation of mast cell degranulation (GO:0043304) | 3.43906694 |
| 95 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.43746138 |
| 96 | regulation of tight junction assembly (GO:2000810) | 3.43373818 |
| 97 | lymph vessel development (GO:0001945) | 3.41845384 |
| 98 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.38069778 |
| 99 | carnitine transmembrane transport (GO:1902603) | 3.37865591 |
| 100 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.37560553 |
| 101 | basement membrane organization (GO:0071711) | 3.34731821 |
| 102 | regulation of cell communication by electrical coupling (GO:0010649) | 3.34079702 |
| 103 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.32106199 |
| 104 | myeloid cell activation involved in immune response (GO:0002275) | 3.30875082 |
| 105 | trabecula formation (GO:0060343) | 3.29407441 |
| 106 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.27583625 |
| 107 | cell migration involved in sprouting angiogenesis (GO:0002042) | 3.27557951 |
| 108 | regulation of membrane repolarization (GO:0060306) | 3.25175731 |
| 109 | regulation of sequestering of triglyceride (GO:0010889) | 3.25067950 |
| 110 | cell communication by electrical coupling (GO:0010644) | 3.25059052 |
| 111 | epithelial cell-cell adhesion (GO:0090136) | 3.24907936 |
| 112 | regulation of cardioblast differentiation (GO:0051890) | 3.23366748 |
| 113 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.22310751 |
| 114 | positive regulation of myotube differentiation (GO:0010831) | 3.21799826 |
| 115 | response to muramyl dipeptide (GO:0032495) | 3.21689545 |
| 116 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.20332184 |
| 117 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.17708503 |
| 118 | regulation of leukocyte degranulation (GO:0043300) | 3.16722651 |
| 119 | negative regulation of potassium ion transport (GO:0043267) | 3.15080996 |
| 120 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.15041151 |
| 121 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.15041151 |
| 122 | muscle contraction (GO:0006936) | 3.14395469 |
| 123 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.14138531 |
| 124 | immunoglobulin mediated immune response (GO:0016064) | 3.13545756 |
| 125 | skeletal muscle contraction (GO:0003009) | 3.13385519 |
| 126 | amino-acid betaine transport (GO:0015838) | 3.12064935 |
| 127 | carnitine transport (GO:0015879) | 3.12064935 |
| 128 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 3.11199434 |
| 129 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.10202161 |
| 130 | negative regulation of T cell mediated immunity (GO:0002710) | 3.09887381 |
| 131 | striated muscle cell development (GO:0055002) | 3.09829954 |
| 132 | regulation of p38MAPK cascade (GO:1900744) | 3.09028977 |
| 133 | cellular response to interleukin-15 (GO:0071350) | 3.07903321 |
| 134 | cardiac muscle cell action potential (GO:0086001) | 3.07192791 |
| 135 | regulation of fatty acid oxidation (GO:0046320) | 3.06982116 |
| 136 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.05937983 |
| 137 | regulation of cardiac muscle contraction (GO:0055117) | 3.04927195 |
| 138 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 3.04177923 |
| 139 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.03789594 |
| 140 | muscle hypertrophy (GO:0014896) | 3.03750586 |
| 141 | cell-substrate junction assembly (GO:0007044) | 3.03235177 |
| 142 | neutrophil chemotaxis (GO:0030593) | 3.02526210 |
| 143 | negative regulation of cell size (GO:0045792) | 3.01538136 |
| 144 | myeloid leukocyte mediated immunity (GO:0002444) | 2.99690780 |
| 145 | glomerular filtration (GO:0003094) | 2.99522823 |
| 146 | NADH metabolic process (GO:0006734) | 2.99147117 |
| 147 | renal filtration (GO:0097205) | 2.98937044 |
| 148 | B cell receptor signaling pathway (GO:0050853) | 2.98194168 |
| 149 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.97477372 |
| 150 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.95629632 |
| 151 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 2.94976151 |
| 152 | neutrophil migration (GO:1990266) | 2.94404143 |
| 153 | lymphangiogenesis (GO:0001946) | 2.93240296 |
| 154 | regulation of heart rate (GO:0002027) | 2.91740259 |
| 155 | positive regulation of mast cell activation (GO:0033005) | 2.91681110 |
| 156 | muscle system process (GO:0003012) | 2.90002972 |
| 157 | adherens junction assembly (GO:0034333) | 2.89675823 |
| 158 | response to inactivity (GO:0014854) | 2.87937049 |
| 159 | blood vessel endothelial cell migration (GO:0043534) | 2.85707729 |
| 160 | regulation of macrophage cytokine production (GO:0010935) | 2.85640873 |
| 161 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.85084145 |
| 162 | regulation of mast cell activation (GO:0033003) | 2.83475800 |
| 163 | endothelium development (GO:0003158) | 2.83353689 |
| 164 | venous blood vessel morphogenesis (GO:0048845) | 2.82747431 |
| 165 | regulation of coenzyme metabolic process (GO:0051196) | 2.82746975 |
| 166 | regulation of cofactor metabolic process (GO:0051193) | 2.82746975 |
| 167 | 2-oxoglutarate metabolic process (GO:0006103) | 2.82330791 |
| 168 | regulation of regulated secretory pathway (GO:1903305) | 2.80656027 |
| 169 | regulation of necroptotic process (GO:0060544) | 2.80546913 |
| 170 | type I interferon signaling pathway (GO:0060337) | 2.80286219 |
| 171 | cellular response to type I interferon (GO:0071357) | 2.80286219 |
| 172 | cell-substrate adherens junction assembly (GO:0007045) | 2.80200446 |
| 173 | focal adhesion assembly (GO:0048041) | 2.80200446 |
| 174 | leukocyte degranulation (GO:0043299) | 2.79918882 |
| 175 | positive regulation of heart contraction (GO:0045823) | 2.79623497 |
| 176 | ventricular cardiac muscle cell development (GO:0055015) | 2.77920420 |
| 177 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.77635756 |
| 178 | response to type I interferon (GO:0034340) | 2.77472412 |
| 179 | negative regulation of type 2 immune response (GO:0002829) | 2.77058703 |
| 180 | glomerular basement membrane development (GO:0032836) | 2.76503694 |
| 181 | muscle cell development (GO:0055001) | 2.76395975 |
| 182 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.75366759 |
| 183 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.74038732 |
| 184 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.72698400 |
| 185 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.72323896 |
| 186 | regulation of tolerance induction (GO:0002643) | 2.71185516 |
| 187 | myeloid leukocyte activation (GO:0002274) | 2.70256398 |
| 188 | negative regulation of interleukin-6 production (GO:0032715) | 2.70227951 |
| 189 | negative regulation of phagocytosis (GO:0050765) | 2.65633070 |
| 190 | dendritic cell migration (GO:0036336) | 2.64624306 |
| 191 | regulation of T cell tolerance induction (GO:0002664) | 2.62522458 |
| 192 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.62508220 |
| 193 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.61665414 |
| 194 | defense response to protozoan (GO:0042832) | 2.60051031 |
| 195 | regulation of B cell differentiation (GO:0045577) | 2.58465393 |
| 196 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.57944681 |
| 197 | negative regulation of innate immune response (GO:0045824) | 2.56768433 |
| 198 | positive regulation of mast cell degranulation (GO:0043306) | 2.55846312 |
| 199 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.55846312 |
| 200 | regulation of platelet aggregation (GO:0090330) | 2.53860456 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.70755305 |
| 2 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 4.05792998 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.86871538 |
| 4 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.77955114 |
| 5 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 3.53177910 |
| 6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.21792957 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.18091446 |
| 8 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.17881350 |
| 9 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.16764405 |
| 10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.10974256 |
| 11 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.03482831 |
| 12 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.02126035 |
| 13 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.99449199 |
| 14 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.99449199 |
| 15 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.91304958 |
| 16 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.77247165 |
| 17 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.74280787 |
| 18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.70739740 |
| 19 | SPI1_23127762_ChIP-Seq_K562_Human | 2.54401191 |
| 20 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.53683624 |
| 21 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.46606050 |
| 22 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.42584321 |
| 23 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.41076422 |
| 24 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.38904873 |
| 25 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.37214459 |
| 26 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.36379858 |
| 27 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.36260734 |
| 28 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.21914680 |
| 29 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 2.20932536 |
| 30 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.19819754 |
| 31 | * MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.14439997 |
| 32 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.12147992 |
| 33 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.11963523 |
| 34 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.11164135 |
| 35 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.09141833 |
| 36 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.09002840 |
| 37 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.08896546 |
| 38 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.04627514 |
| 39 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.03106236 |
| 40 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.02133471 |
| 41 | MAF_26560356_Chip-Seq_TH1_Human | 2.00958477 |
| 42 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.99516839 |
| 43 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.96995772 |
| 44 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.96122470 |
| 45 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.92419601 |
| 46 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.87480593 |
| 47 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.83709076 |
| 48 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.83050717 |
| 49 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.82732832 |
| 50 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.82630274 |
| 51 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.81472510 |
| 52 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.81051645 |
| 53 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.78600195 |
| 54 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.78554043 |
| 55 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.78113188 |
| 56 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.77121382 |
| 57 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.76549330 |
| 58 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.76023812 |
| 59 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.72690696 |
| 60 | UTX_26944678_Chip-Seq_JUKART_Human | 1.71960563 |
| 61 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.71290265 |
| 62 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.68967447 |
| 63 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.66599544 |
| 64 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.66200768 |
| 65 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.62638345 |
| 66 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.58768246 |
| 67 | MYB_26560356_Chip-Seq_TH2_Human | 1.58038263 |
| 68 | CJUN_26792858_Chip-Seq_BT549_Human | 1.57612349 |
| 69 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55409290 |
| 70 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.55209488 |
| 71 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.55207812 |
| 72 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.54869117 |
| 73 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.54433773 |
| 74 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.54212531 |
| 75 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.54184283 |
| 76 | MYC_22102868_ChIP-Seq_BL_Human | 1.53482098 |
| 77 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.52028584 |
| 78 | ATF3_27146783_Chip-Seq_COLON_Human | 1.49461423 |
| 79 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.46576205 |
| 80 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.45663812 |
| 81 | MYB_26560356_Chip-Seq_TH1_Human | 1.41277117 |
| 82 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.40975508 |
| 83 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.40347995 |
| 84 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.40267576 |
| 85 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.40258105 |
| 86 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.39867171 |
| 87 | * GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.38561743 |
| 88 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.38216555 |
| 89 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.37885964 |
| 90 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.37403357 |
| 91 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.36645404 |
| 92 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.36535645 |
| 93 | MAF_26560356_Chip-Seq_TH2_Human | 1.35518313 |
| 94 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.35382587 |
| 95 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.33629991 |
| 96 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33293839 |
| 97 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.32584632 |
| 98 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.32491307 |
| 99 | GATA1_22025678_ChIP-Seq_K562_Human | 1.31602467 |
| 100 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.29957181 |
| 101 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.29364526 |
| 102 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.29072509 |
| 103 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.28358206 |
| 104 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.27241759 |
| 105 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.27179518 |
| 106 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.26944296 |
| 107 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.25993157 |
| 108 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.24350065 |
| 109 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.24083788 |
| 110 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.23766813 |
| 111 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.21632529 |
| 112 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.21228267 |
| 113 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.21020494 |
| 114 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.20161958 |
| 115 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.20012978 |
| 116 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18331653 |
| 117 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17979197 |
| 118 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17571916 |
| 119 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16714267 |
| 120 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.16660970 |
| 121 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.16322970 |
| 122 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.15971400 |
| 123 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.14153188 |
| 124 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13998636 |
| 125 | GATA2_19941826_ChIP-Seq_K562_Human | 1.13816479 |
| 126 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.12989135 |
| 127 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.12513220 |
| 128 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.12386679 |
| 129 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.11039696 |
| 130 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.10603236 |
| 131 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.10466414 |
| 132 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.10193765 |
| 133 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.10193765 |
| 134 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.09065681 |
| 135 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07886476 |
| 136 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07831996 |
| 137 | GATA1_19941826_ChIP-Seq_K562_Human | 1.06880414 |
| 138 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.06505723 |
| 139 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.06091653 |
| 140 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.06040955 |
| 141 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05209342 |
| 142 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.04560205 |
| 143 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.03979117 |
| 144 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.03911464 |
| 145 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.03056012 |
| 146 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.02969539 |
| 147 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.02369012 |
| 148 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.01796588 |
| 149 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.01469022 |
| 150 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.00703081 |
| 151 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.00068184 |
| 152 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.99458188 |
| 153 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.98600193 |
| 154 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96001748 |
| 155 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.95999831 |
| 156 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.95697243 |
| 157 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94414203 |
| 158 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.92484298 |
| 159 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.92317625 |
| 160 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.91334871 |
| 161 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.90846126 |
| 162 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.90691479 |
| 163 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.87843315 |
| 164 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.87099223 |
| 165 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.86654075 |
| 166 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.86654075 |
| 167 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.86305416 |
| 168 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.85836201 |
| 169 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.85800117 |
| 170 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.85301075 |
| 171 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.84532820 |
| 172 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.80298085 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 5.16764949 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 5.05088320 |
| 3 | MP0004084_abnormal_cardiac_muscle | 4.89447502 |
| 4 | MP0000751_myopathy | 4.54684731 |
| 5 | MP0003303_peritoneal_inflammation | 3.98332337 |
| 6 | MP0003436_decreased_susceptibility_to | 3.64705288 |
| 7 | MP0004215_abnormal_myocardial_fiber | 3.59598598 |
| 8 | MP0003646_muscle_fatigue | 3.51009645 |
| 9 | MP0004036_abnormal_muscle_relaxation | 3.49439264 |
| 10 | MP0005330_cardiomyopathy | 3.16906093 |
| 11 | * MP0000749_muscle_degeneration | 3.05141054 |
| 12 | MP0010368_abnormal_lymphatic_system | 2.93599951 |
| 13 | MP0008438_abnormal_cutaneous_collagen | 2.89527988 |
| 14 | MP0002419_abnormal_innate_immunity | 2.84987624 |
| 15 | MP0004272_abnormal_basement_membrane | 2.79485458 |
| 16 | MP0005451_abnormal_body_composition | 2.79230076 |
| 17 | * MP0004087_abnormal_muscle_fiber | 2.77039508 |
| 18 | MP0001835_abnormal_antigen_presentation | 2.74529758 |
| 19 | MP0003191_abnormal_cellular_cholesterol | 2.55741211 |
| 20 | MP0008775_abnormal_heart_ventricle | 2.54644927 |
| 21 | MP0003705_abnormal_hypodermis_morpholog | 2.53639071 |
| 22 | MP0002972_abnormal_cardiac_muscle | 2.52796564 |
| 23 | MP0008260_abnormal_autophagy | 2.51339381 |
| 24 | * MP0000750_abnormal_muscle_regeneration | 2.50495279 |
| 25 | MP0003300_gastrointestinal_ulcer | 2.50009543 |
| 26 | MP0005025_abnormal_response_to | 2.42763834 |
| 27 | MP0003279_aneurysm | 2.42426307 |
| 28 | MP0005620_abnormal_muscle_contractility | 2.36364113 |
| 29 | MP0009785_altered_susceptibility_to | 2.35704218 |
| 30 | MP0004145_abnormal_muscle_electrophysio | 2.34197560 |
| 31 | MP0010630_abnormal_cardiac_muscle | 2.34096172 |
| 32 | MP0006138_congestive_heart_failure | 2.31510097 |
| 33 | MP0004130_abnormal_muscle_cell | 2.28613090 |
| 34 | MP0001544_abnormal_cardiovascular_syste | 2.23875696 |
| 35 | MP0005385_cardiovascular_system_phenoty | 2.23875696 |
| 36 | MP0003828_pulmonary_edema | 2.23472591 |
| 37 | MP0000685_abnormal_immune_system | 2.22080848 |
| 38 | * MP0002106_abnormal_muscle_physiology | 2.14138638 |
| 39 | MP0005000_abnormal_immune_tolerance | 2.13605665 |
| 40 | MP0001790_abnormal_immune_system | 2.12858515 |
| 41 | MP0005387_immune_system_phenotype | 2.12858515 |
| 42 | MP0005623_abnormal_meninges_morphology | 2.07912295 |
| 43 | MP0001800_abnormal_humoral_immune | 2.06483218 |
| 44 | MP0000465_gastrointestinal_hemorrhage | 2.03609973 |
| 45 | MP0001879_abnormal_lymphatic_vessel | 2.00673449 |
| 46 | MP0001533_abnormal_skeleton_physiology | 1.99086079 |
| 47 | MP0006082_CNS_inflammation | 1.98759222 |
| 48 | MP0002420_abnormal_adaptive_immunity | 1.97517384 |
| 49 | MP0001819_abnormal_immune_cell | 1.95457676 |
| 50 | MP0004484_altered_response_of | 1.95272646 |
| 51 | MP0002723_abnormal_immune_serum | 1.94214575 |
| 52 | MP0005670_abnormal_white_adipose | 1.94112990 |
| 53 | MP0005275_abnormal_skin_tensile | 1.93401180 |
| 54 | MP0003137_abnormal_impulse_conducting | 1.93326459 |
| 55 | * MP0000759_abnormal_skeletal_muscle | 1.92916661 |
| 56 | MP0005464_abnormal_platelet_physiology | 1.91818782 |
| 57 | * MP0002269_muscular_atrophy | 1.88287284 |
| 58 | MP0003566_abnormal_cell_adhesion | 1.87528316 |
| 59 | MP0002452_abnormal_antigen_presenting | 1.86863401 |
| 60 | * MP0005369_muscle_phenotype | 1.80501379 |
| 61 | MP0005671_abnormal_response_to | 1.77692623 |
| 62 | MP0000013_abnormal_adipose_tissue | 1.72918779 |
| 63 | * MP0000747_muscle_weakness | 1.69674791 |
| 64 | MP0005666_abnormal_adipose_tissue | 1.62941376 |
| 65 | MP0002132_abnormal_respiratory_system | 1.61084419 |
| 66 | MP0003950_abnormal_plasma_membrane | 1.61029221 |
| 67 | MP0004085_abnormal_heartbeat | 1.60288634 |
| 68 | MP0002148_abnormal_hypersensitivity_rea | 1.58619734 |
| 69 | MP0002405_respiratory_system_inflammati | 1.56684855 |
| 70 | MP0009278_abnormal_bone_marrow | 1.56147775 |
| 71 | MP0004233_abnormal_muscle_weight | 1.55408823 |
| 72 | MP0003172_abnormal_lysosome_physiology | 1.54956305 |
| 73 | MP0002127_abnormal_cardiovascular_syste | 1.54420660 |
| 74 | MP0000733_abnormal_muscle_development | 1.49637410 |
| 75 | MP0004947_skin_inflammation | 1.43289894 |
| 76 | MP0002398_abnormal_bone_marrow | 1.41864309 |
| 77 | MP0000716_abnormal_immune_system | 1.41177233 |
| 78 | MP0003075_altered_response_to | 1.39501280 |
| 79 | MP0004883_abnormal_blood_vessel | 1.38653314 |
| 80 | MP0003763_abnormal_thymus_physiology | 1.37598520 |
| 81 | MP0010155_abnormal_intestine_physiology | 1.37422479 |
| 82 | MP0002332_abnormal_exercise_endurance | 1.37249963 |
| 83 | MP0004510_myositis | 1.37196032 |
| 84 | MP0005375_adipose_tissue_phenotype | 1.36679632 |
| 85 | MP0003221_abnormal_cardiomyocyte_apopto | 1.36416910 |
| 86 | MP0004185_abnormal_adipocyte_glucose | 1.35618905 |
| 87 | MP0001845_abnormal_inflammatory_respons | 1.33596480 |
| 88 | MP0002108_abnormal_muscle_morphology | 1.32669767 |
| 89 | MP0001851_eye_inflammation | 1.26157483 |
| 90 | MP0000767_abnormal_smooth_muscle | 1.25969306 |
| 91 | MP0009764_decreased_sensitivity_to | 1.24522349 |
| 92 | MP0002396_abnormal_hematopoietic_system | 1.23967004 |
| 93 | MP0004381_abnormal_hair_follicle | 1.23945385 |
| 94 | MP0000003_abnormal_adipose_tissue | 1.23182838 |
| 95 | MP0003183_abnormal_peptide_metabolism | 1.22185443 |
| 96 | MP0000858_altered_metastatic_potential | 1.21840670 |
| 97 | MP0002998_abnormal_bone_remodeling | 1.20785374 |
| 98 | MP0000266_abnormal_heart_morphology | 1.19950112 |
| 99 | MP0002722_abnormal_immune_system | 1.17270471 |
| 100 | MP0002128_abnormal_blood_circulation | 1.16765563 |
| 101 | MP0005503_abnormal_tendon_morphology | 1.16667925 |
| 102 | MP0005164_abnormal_response_to | 1.15843483 |
| 103 | MP0003567_abnormal_fetal_cardiomyocyte | 1.15606141 |
| 104 | MP0005397_hematopoietic_system_phenotyp | 1.13839422 |
| 105 | MP0001545_abnormal_hematopoietic_system | 1.13839422 |
| 106 | MP0001958_emphysema | 1.12848385 |
| 107 | MP0000689_abnormal_spleen_morphology | 1.12097948 |
| 108 | MP0002429_abnormal_blood_cell | 1.12056941 |
| 109 | MP0005165_increased_susceptibility_to | 1.11489275 |
| 110 | MP0005166_decreased_susceptibility_to | 1.10264695 |
| 111 | * MP0008469_abnormal_protein_level | 1.09307920 |
| 112 | MP0000343_altered_response_to | 1.09211625 |
| 113 | MP0003866_abnormal_defecation | 1.07799842 |
| 114 | MP0005167_abnormal_blood-brain_barrier | 1.07132042 |
| 115 | MP0003656_abnormal_erythrocyte_physiolo | 1.07110359 |
| 116 | MP0003690_abnormal_glial_cell | 1.05298487 |
| 117 | MP0002138_abnormal_hepatobiliary_system | 1.04062921 |
| 118 | MP0003045_fibrosis | 1.01193951 |
| 119 | MP0003091_abnormal_cell_migration | 0.99855968 |
| 120 | MP0002277_abnormal_respiratory_mucosa | 0.98440080 |
| 121 | MP0005058_abnormal_lysosome_morphology | 0.97819822 |
| 122 | MP0000703_abnormal_thymus_morphology | 0.96788531 |
| 123 | MP0008004_abnormal_stomach_pH | 0.93290398 |
| 124 | MP0002925_abnormal_cardiovascular_devel | 0.90399010 |
| 125 | MP0002295_abnormal_pulmonary_circulatio | 0.88732768 |
| 126 | MP0006054_spinal_hemorrhage | 0.87729416 |
| 127 | MP0009333_abnormal_splenocyte_physiolog | 0.84119726 |
| 128 | MP0003448_altered_tumor_morphology | 0.83579202 |
| 129 | MP0001614_abnormal_blood_vessel | 0.83179929 |
| 130 | MP0005409_darkened_coat_color | 0.82421986 |
| 131 | MP0002933_joint_inflammation | 0.81796084 |
| 132 | MP0002166_altered_tumor_susceptibility | 0.79943741 |
| 133 | MP0005390_skeleton_phenotype | 0.79079077 |
| 134 | MP0006036_abnormal_mitochondrial_physio | 0.76022222 |
| 135 | MP0002971_abnormal_brown_adipose | 0.74754284 |
| 136 | MP0010352_gastrointestinal_tract_polyps | 0.74455920 |
| 137 | MP0009780_abnormal_chondrocyte_physiolo | 0.74281883 |
| 138 | MP0005023_abnormal_wound_healing | 0.72226827 |
| 139 | MP0009384_cardiac_valve_regurgitation | 0.72064448 |
| 140 | MP0000230_abnormal_systemic_arterial | 0.71319894 |
| 141 | MP0002234_abnormal_pharynx_morphology | 0.70079983 |
| 142 | MP0002896_abnormal_bone_mineralization | 0.69594434 |
| 143 | MP0005595_abnormal_vascular_smooth | 0.65893217 |
| 144 | MP0003984_embryonic_growth_retardation | 0.65456550 |
| 145 | MP0003941_abnormal_skin_development | 0.65342082 |
| 146 | MP0002088_abnormal_embryonic_growth/wei | 0.64192411 |
| 147 | MP0001784_abnormal_fluid_regulation | 0.59926967 |
| 148 | MP0002877_abnormal_melanocyte_morpholog | 0.59675108 |
| 149 | MP0003385_abnormal_body_wall | 0.59605098 |
| 150 | MP0005187_abnormal_penis_morphology | 0.54643790 |
| 151 | MP0000249_abnormal_blood_vessel | 0.54434937 |
| 152 | MP0005508_abnormal_skeleton_morphology | 0.51661605 |
| 153 | MP0005266_abnormal_metabolism | 0.48310260 |
| 154 | MP0002168_other_aberrant_phenotype | 0.46861968 |
| 155 | MP0001299_abnormal_eye_distance/ | 0.45820394 |
| 156 | MP0001672_abnormal_embryogenesis/_devel | 0.43566358 |
| 157 | MP0005380_embryogenesis_phenotype | 0.43566358 |
| 158 | MP0009115_abnormal_fat_cell | 0.43179238 |
| 159 | MP0010030_abnormal_orbit_morphology | 0.42644535 |
| 160 | MP0002060_abnormal_skin_morphology | 0.42474497 |
| 161 | MP0008961_abnormal_basal_metabolism | 0.40307766 |
| 162 | MP0003935_abnormal_craniofacial_develop | 0.38896294 |
| 163 | MP0004858_abnormal_nervous_system | 0.38566731 |
| 164 | MP0002086_abnormal_extraembryonic_tissu | 0.37858734 |
| 165 | MP0001727_abnormal_embryo_implantation | 0.37831233 |
| 166 | MP0001915_intracranial_hemorrhage | 0.37627116 |
| 167 | MP0003948_abnormal_gas_homeostasis | 0.37422715 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 6.49859897 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.94993975 |
| 3 | Ventricular tachycardia (HP:0004756) | 5.42802569 |
| 4 | * Muscle fiber splitting (HP:0003555) | 5.16658982 |
| 5 | Recurrent abscess formation (HP:0002722) | 5.14866506 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 4.94221789 |
| 7 | Myositis (HP:0100614) | 4.90987419 |
| 8 | Calf muscle hypertrophy (HP:0008981) | 4.90203212 |
| 9 | Right ventricular cardiomyopathy (HP:0011663) | 4.78332629 |
| 10 | Orchitis (HP:0100796) | 4.69356364 |
| 11 | Exercise-induced muscle cramps (HP:0003710) | 4.67849164 |
| 12 | Exercise-induced myalgia (HP:0003738) | 4.64195681 |
| 13 | Abnormality of the calf musculature (HP:0001430) | 4.60681602 |
| 14 | Abnormality of macrophages (HP:0004311) | 4.57187468 |
| 15 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.51904418 |
| 16 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.49972459 |
| 17 | Atrial fibrillation (HP:0005110) | 4.49459820 |
| 18 | * Hyporeflexia of lower limbs (HP:0002600) | 4.48515055 |
| 19 | Lipoatrophy (HP:0100578) | 4.36509617 |
| 20 | Optic neuritis (HP:0100653) | 4.30344075 |
| 21 | Retrobulbar optic neuritis (HP:0100654) | 4.30344075 |
| 22 | Spontaneous hematomas (HP:0007420) | 4.22647144 |
| 23 | Type 1 muscle fiber predominance (HP:0003803) | 4.22485180 |
| 24 | Primary atrial arrhythmia (HP:0001692) | 4.19344776 |
| 25 | Supraventricular arrhythmia (HP:0005115) | 4.09490576 |
| 26 | Supraventricular tachycardia (HP:0004755) | 4.01445843 |
| 27 | Protrusio acetabuli (HP:0003179) | 3.99323240 |
| 28 | * Increased connective tissue (HP:0009025) | 3.94763396 |
| 29 | Subaortic stenosis (HP:0001682) | 3.81300953 |
| 30 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.81300953 |
| 31 | Stomatitis (HP:0010280) | 3.79364928 |
| 32 | Gastrointestinal infarctions (HP:0005244) | 3.74146972 |
| 33 | Myoglobinuria (HP:0002913) | 3.67765934 |
| 34 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.60630601 |
| 35 | Myotonia (HP:0002486) | 3.58766183 |
| 36 | * EMG: myopathic abnormalities (HP:0003458) | 3.57165504 |
| 37 | Muscle fiber inclusion bodies (HP:0100299) | 3.50441423 |
| 38 | Hypochromic microcytic anemia (HP:0004840) | 3.49125359 |
| 39 | Premature rupture of membranes (HP:0001788) | 3.47733236 |
| 40 | Dilated cardiomyopathy (HP:0001644) | 3.46667959 |
| 41 | Bundle branch block (HP:0011710) | 3.45055196 |
| 42 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.44145042 |
| 43 | Syncope (HP:0001279) | 3.42741696 |
| 44 | Obstructive lung disease (HP:0006536) | 3.36458639 |
| 45 | Chronic obstructive pulmonary disease (HP:0006510) | 3.36458639 |
| 46 | Gingivitis (HP:0000230) | 3.34209538 |
| 47 | Keratoconjunctivitis sicca (HP:0001097) | 3.24592579 |
| 48 | * Difficulty climbing stairs (HP:0003551) | 3.22633756 |
| 49 | Asymmetric septal hypertrophy (HP:0001670) | 3.22295356 |
| 50 | Recurrent fungal infections (HP:0002841) | 3.20118519 |
| 51 | Peritonitis (HP:0002586) | 3.19654073 |
| 52 | * Difficulty running (HP:0009046) | 3.19618407 |
| 53 | Prolonged bleeding time (HP:0003010) | 3.18988601 |
| 54 | Atrioventricular block (HP:0001678) | 3.17451928 |
| 55 | Prolonged QT interval (HP:0001657) | 3.15232304 |
| 56 | Mediastinal lymphadenopathy (HP:0100721) | 3.15182624 |
| 57 | Palpitations (HP:0001962) | 3.14776185 |
| 58 | Broad metatarsal (HP:0001783) | 3.14545984 |
| 59 | Round ear (HP:0100830) | 3.13934898 |
| 60 | Recurrent skin infections (HP:0001581) | 3.11030677 |
| 61 | Ventricular arrhythmia (HP:0004308) | 3.05175394 |
| 62 | Chest pain (HP:0100749) | 3.04857357 |
| 63 | Meningitis (HP:0001287) | 3.04181806 |
| 64 | Cerebral aneurysm (HP:0004944) | 2.98655198 |
| 65 | Heart block (HP:0012722) | 2.98170796 |
| 66 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.98011418 |
| 67 | Abnormal atrioventricular conduction (HP:0005150) | 2.96832480 |
| 68 | Cellulitis (HP:0100658) | 2.96132607 |
| 69 | Increased IgE level (HP:0003212) | 2.94904035 |
| 70 | Spinal rigidity (HP:0003306) | 2.94690180 |
| 71 | Keratoconjunctivitis (HP:0001096) | 2.93902182 |
| 72 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.93885825 |
| 73 | Distal arthrogryposis (HP:0005684) | 2.91930290 |
| 74 | Rhabdomyolysis (HP:0003201) | 2.88771496 |
| 75 | Urticaria (HP:0001025) | 2.84635743 |
| 76 | Episodic fever (HP:0001954) | 2.77788163 |
| 77 | Hypochromic anemia (HP:0001931) | 2.77327378 |
| 78 | Nemaline bodies (HP:0003798) | 2.75158482 |
| 79 | Distal lower limb muscle weakness (HP:0009053) | 2.75137789 |
| 80 | Epistaxis (HP:0000421) | 2.69873777 |
| 81 | Amyloidosis (HP:0011034) | 2.69389935 |
| 82 | Hypoplastic ischia (HP:0003175) | 2.68018402 |
| 83 | Encephalitis (HP:0002383) | 2.67409782 |
| 84 | Hemoptysis (HP:0002105) | 2.64036672 |
| 85 | Distal lower limb amyotrophy (HP:0008944) | 2.63681744 |
| 86 | Arterial thrombosis (HP:0004420) | 2.62956768 |
| 87 | Gingival bleeding (HP:0000225) | 2.62923060 |
| 88 | Hip contracture (HP:0003273) | 2.62370045 |
| 89 | Recurrent cutaneous fungal infections (HP:0011370) | 2.59733713 |
| 90 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.59733713 |
| 91 | Vasculitis (HP:0002633) | 2.59041863 |
| 92 | Ventricular fibrillation (HP:0001663) | 2.55138463 |
| 93 | * Increased variability in muscle fiber diameter (HP:0003557) | 2.54454448 |
| 94 | Scapular winging (HP:0003691) | 2.53047116 |
| 95 | Ankle contracture (HP:0006466) | 2.51634339 |
| 96 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.49192926 |
| 97 | * Abnormality of skeletal muscle fiber size (HP:0012084) | 2.49039932 |
| 98 | Microcytic anemia (HP:0001935) | 2.43209597 |
| 99 | Abnormality of the ischium (HP:0003174) | 2.42012338 |
| 100 | Pulmonary embolism (HP:0002204) | 2.36017487 |
| 101 | Wrist flexion contracture (HP:0001239) | 2.35262177 |
| 102 | Neck muscle weakness (HP:0000467) | 2.34598443 |
| 103 | Muscle stiffness (HP:0003552) | 2.34010104 |
| 104 | Abnormal platelet volume (HP:0011876) | 2.31746852 |
| 105 | Lymphangioma (HP:0100764) | 2.30288715 |
| 106 | Generalized muscle weakness (HP:0003324) | 2.27548777 |
| 107 | Abnormality of the peritoneum (HP:0002585) | 2.27226175 |
| 108 | Anorexia (HP:0002039) | 2.26855195 |
| 109 | Limb-girdle muscle atrophy (HP:0003797) | 2.26792431 |
| 110 | Gowers sign (HP:0003391) | 2.24102652 |
| 111 | Shallow orbits (HP:0000586) | 2.21187770 |
| 112 | Facial diplegia (HP:0001349) | 2.20325583 |
| 113 | Pulmonary infiltrates (HP:0002113) | 2.19692297 |
| 114 | Aneurysm (HP:0002617) | 2.19217912 |
| 115 | Leukocytosis (HP:0001974) | 2.18158364 |
| 116 | Metaphyseal cupping (HP:0003021) | 2.16670826 |
| 117 | Osteomyelitis (HP:0002754) | 2.16093366 |
| 118 | Abnormality of the endocardium (HP:0004306) | 2.12334497 |
| 119 | Aortic dissection (HP:0002647) | 2.11958861 |
| 120 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.10761554 |
| 121 | EMG: neuropathic changes (HP:0003445) | 2.09859479 |
| 122 | Abnormal EKG (HP:0003115) | 2.08555855 |
| 123 | Inflammation of the large intestine (HP:0002037) | 2.06593875 |
| 124 | Ulnar deviation of the wrist (HP:0003049) | 2.06481064 |
| 125 | Testicular atrophy (HP:0000029) | 2.06407814 |
| 126 | Limited hip movement (HP:0008800) | 2.03007959 |
| 127 | T lymphocytopenia (HP:0005403) | 2.01171835 |
| 128 | Toxemia of pregnancy (HP:0100603) | 2.00901853 |
| 129 | Hematochezia (HP:0002573) | 1.99341334 |
| 130 | Subacute progressive viral hepatitis (HP:0006572) | 1.99293604 |
| 131 | Gastrointestinal inflammation (HP:0004386) | 1.98657543 |
| 132 | Vertigo (HP:0002321) | 1.98648795 |
| 133 | Lower limb amyotrophy (HP:0007210) | 1.97629731 |
| 134 | Abnormality of the foot musculature (HP:0001436) | 1.96756019 |
| 135 | Foot dorsiflexor weakness (HP:0009027) | 1.95826969 |
| 136 | Aortic aneurysm (HP:0004942) | 1.93481670 |
| 137 | Abnormality of T cell number (HP:0011839) | 1.93089145 |
| 138 | Palmoplantar keratoderma (HP:0000982) | 1.87055230 |
| 139 | Slow saccadic eye movements (HP:0000514) | 1.86704707 |
| 140 | Myopathic facies (HP:0002058) | 1.86115851 |
| 141 | Mesangial abnormality (HP:0001966) | 1.84582870 |
| 142 | Petechiae (HP:0000967) | 1.84425351 |
| 143 | Menorrhagia (HP:0000132) | 1.83963272 |
| 144 | Polycythemia (HP:0001901) | 1.83649649 |
| 145 | Granulocytopenia (HP:0001913) | 1.83526919 |
| 146 | Fragile skin (HP:0001030) | 1.83482700 |
| 147 | Sepsis (HP:0100806) | 1.82567898 |
| 148 | Malignant hyperthermia (HP:0002047) | 1.80670619 |
| 149 | Limb-girdle muscle weakness (HP:0003325) | 1.79782801 |
| 150 | Hypoglycemic coma (HP:0001325) | 1.79290061 |
| 151 | Abnormality of the pleura (HP:0002103) | 1.79205975 |
| 152 | Calcaneovalgus deformity (HP:0001848) | 1.79174167 |
| 153 | Atrophic scars (HP:0001075) | 1.78831891 |
| 154 | Sudden cardiac death (HP:0001645) | 1.77829162 |
| 155 | Recurrent viral infections (HP:0004429) | 1.77305382 |
| 156 | Pustule (HP:0200039) | 1.77165797 |
| 157 | * Muscular dystrophy (HP:0003560) | 1.76969654 |
| 158 | Acne (HP:0001061) | 1.76678582 |
| 159 | Congestive heart failure (HP:0001635) | 1.76203770 |
| 160 | Left ventricular hypertrophy (HP:0001712) | 1.75189417 |
| 161 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.74185837 |
| 162 | Hemiplegia (HP:0002301) | 1.73824117 |
| 163 | Ketoacidosis (HP:0001993) | 1.73810389 |
| 164 | Bladder diverticulum (HP:0000015) | 1.73512562 |
| 165 | Absent phalangeal crease (HP:0006109) | 1.73206234 |
| 166 | Skin ulcer (HP:0200042) | 1.72425185 |
| 167 | Bulbar palsy (HP:0001283) | 1.71256126 |
| 168 | Distal upper limb amyotrophy (HP:0007149) | 1.70133447 |
| 169 | Upper limb amyotrophy (HP:0009129) | 1.70133447 |
| 170 | Knee flexion contracture (HP:0006380) | 1.69925974 |
| 171 | Neonatal death (HP:0003811) | 1.69492214 |
| 172 | Frequent falls (HP:0002359) | 1.69474276 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 5.27174434 |
| 2 | TIE1 | 4.60948701 |
| 3 | RIPK4 | 4.02105932 |
| 4 | TRIB3 | 3.83420382 |
| 5 | OBSCN | 3.46633556 |
| 6 | KDR | 3.15118588 |
| 7 | PKN2 | 2.94006454 |
| 8 | MYLK | 2.67981664 |
| 9 | BLK | 2.67817837 |
| 10 | PHKG1 | 2.67359583 |
| 11 | PHKG2 | 2.67359583 |
| 12 | LMTK2 | 2.66174397 |
| 13 | FES | 2.66084232 |
| 14 | CSK | 2.61037787 |
| 15 | IRAK4 | 2.60626478 |
| 16 | DMPK | 2.58258058 |
| 17 | MAP4K1 | 2.55639048 |
| 18 | TYK2 | 2.28993083 |
| 19 | PDK3 | 2.28587953 |
| 20 | PDK4 | 2.28587953 |
| 21 | ZAP70 | 2.13333597 |
| 22 | RIPK1 | 2.01073963 |
| 23 | PRPF4B | 2.00693426 |
| 24 | TNK2 | 1.90985559 |
| 25 | PDGFRA | 1.82212990 |
| 26 | GRK6 | 1.80769523 |
| 27 | TAOK1 | 1.79520364 |
| 28 | PDK2 | 1.78768693 |
| 29 | PIK3CA | 1.69784466 |
| 30 | NEK1 | 1.63971816 |
| 31 | KSR2 | 1.63709342 |
| 32 | HCK | 1.62529617 |
| 33 | LATS2 | 1.61505012 |
| 34 | JAK3 | 1.57774544 |
| 35 | TGFBR2 | 1.57634778 |
| 36 | FGR | 1.51101155 |
| 37 | MAP3K13 | 1.46859806 |
| 38 | BTK | 1.44581040 |
| 39 | BCKDK | 1.44048726 |
| 40 | EPHB2 | 1.42142165 |
| 41 | MAP3K6 | 1.40136269 |
| 42 | LATS1 | 1.34748903 |
| 43 | PTK2B | 1.33868765 |
| 44 | MUSK | 1.31354303 |
| 45 | PAK3 | 1.31350151 |
| 46 | MARK2 | 1.26814343 |
| 47 | JAK2 | 1.23540055 |
| 48 | SYK | 1.23205510 |
| 49 | SIK1 | 1.22784058 |
| 50 | MAP2K3 | 1.22428029 |
| 51 | PRKD1 | 1.16924901 |
| 52 | ERN1 | 1.16566540 |
| 53 | MAP3K14 | 1.14427256 |
| 54 | ILK | 1.13064073 |
| 55 | MAPKAPK3 | 1.11653907 |
| 56 | PTK6 | 1.10591331 |
| 57 | YES1 | 1.09445429 |
| 58 | FER | 1.05065654 |
| 59 | TBK1 | 1.04998572 |
| 60 | DDR2 | 1.03163313 |
| 61 | ROCK1 | 1.02244935 |
| 62 | EPHB1 | 1.01172114 |
| 63 | IKBKE | 1.00556965 |
| 64 | WNK4 | 1.00162017 |
| 65 | LYN | 0.98254879 |
| 66 | PRKD2 | 0.97495220 |
| 67 | MAP3K3 | 0.96810246 |
| 68 | MAP2K4 | 0.96364046 |
| 69 | STK38L | 0.95880376 |
| 70 | MAPK12 | 0.95155150 |
| 71 | TRPM7 | 0.94257268 |
| 72 | PTK2 | 0.91040131 |
| 73 | TAOK2 | 0.89917354 |
| 74 | PRKG2 | 0.88811778 |
| 75 | LCK | 0.87369274 |
| 76 | PIK3CG | 0.85394446 |
| 77 | TGFBR1 | 0.84527451 |
| 78 | TXK | 0.83629640 |
| 79 | CAMK1D | 0.82939340 |
| 80 | SGK3 | 0.81830540 |
| 81 | PDK1 | 0.79508924 |
| 82 | MTOR | 0.78877473 |
| 83 | MAP3K7 | 0.78196938 |
| 84 | PRKAA2 | 0.78070390 |
| 85 | ITK | 0.77255420 |
| 86 | CDC42BPA | 0.76635868 |
| 87 | MAP3K2 | 0.75640421 |
| 88 | IRAK1 | 0.75577530 |
| 89 | STK10 | 0.74855229 |
| 90 | PAK2 | 0.73970264 |
| 91 | TEC | 0.73526443 |
| 92 | SMG1 | 0.72929715 |
| 93 | STK24 | 0.72597136 |
| 94 | MAP2K1 | 0.72556977 |
| 95 | MARK3 | 0.72261786 |
| 96 | LRRK2 | 0.72003772 |
| 97 | PRKAA1 | 0.71735208 |
| 98 | PINK1 | 0.71296478 |
| 99 | PRKD3 | 0.70579427 |
| 100 | CAMK2D | 0.68823577 |
| 101 | KIT | 0.64918926 |
| 102 | CSF1R | 0.63805666 |
| 103 | RET | 0.63371966 |
| 104 | PAK4 | 0.63059567 |
| 105 | IRAK2 | 0.61352088 |
| 106 | CAMK1G | 0.61347658 |
| 107 | SIK3 | 0.60798330 |
| 108 | STK11 | 0.60679230 |
| 109 | FYN | 0.60423599 |
| 110 | INSRR | 0.59857063 |
| 111 | ICK | 0.58666181 |
| 112 | ZAK | 0.58431083 |
| 113 | KSR1 | 0.57482230 |
| 114 | SGK2 | 0.56695907 |
| 115 | MATK | 0.56108873 |
| 116 | DYRK1B | 0.55966728 |
| 117 | PDGFRB | 0.55453163 |
| 118 | MAP2K6 | 0.55033635 |
| 119 | NEK9 | 0.54625115 |
| 120 | ROCK2 | 0.54256989 |
| 121 | FLT3 | 0.52754704 |
| 122 | MAP3K5 | 0.52754332 |
| 123 | RAF1 | 0.52710159 |
| 124 | STK38 | 0.52225974 |
| 125 | DAPK3 | 0.51712523 |
| 126 | WNK1 | 0.51639044 |
| 127 | FGFR4 | 0.50008380 |
| 128 | MOS | 0.49575885 |
| 129 | MAP3K10 | 0.48821066 |
| 130 | AKT2 | 0.48697002 |
| 131 | TESK2 | 0.48452017 |
| 132 | CDK19 | 0.47873657 |
| 133 | BMX | 0.47521833 |
| 134 | DAPK2 | 0.44698755 |
| 135 | MET | 0.44403743 |
| 136 | RPS6KA2 | 0.42956186 |
| 137 | PRKCH | 0.41810997 |
| 138 | PDPK1 | 0.39723373 |
| 139 | LIMK1 | 0.38237130 |
| 140 | FGFR1 | 0.36514612 |
| 141 | TAOK3 | 0.36021051 |
| 142 | HIPK2 | 0.34469963 |
| 143 | CAMK4 | 0.34046049 |
| 144 | MAPKAPK2 | 0.33981982 |
| 145 | PRKACB | 0.33619774 |
| 146 | FGFR3 | 0.31056611 |
| 147 | RPS6KL1 | 0.29394213 |
| 148 | RPS6KC1 | 0.29394213 |
| 149 | EPHA3 | 0.29224373 |
| 150 | MAP3K11 | 0.28863838 |
| 151 | EPHA2 | 0.26653375 |
| 152 | GRK7 | 0.26539657 |
| 153 | PRKCE | 0.25659180 |
| 154 | STK3 | 0.24938564 |
| 155 | PRKACG | 0.22999224 |
| 156 | MAP3K1 | 0.22862120 |
| 157 | MAPK7 | 0.22748000 |
| 158 | RPS6KA6 | 0.21774862 |
| 159 | JAK1 | 0.20879706 |
| 160 | STK4 | 0.20433032 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.67113886 |
| 2 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.89168996 |
| 3 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.86002742 |
| 4 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.55191320 |
| 5 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.07995337 |
| 6 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.98547022 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.85908560 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 2.72231805 |
| 9 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.56370861 |
| 10 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.50817595 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.39620373 |
| 12 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.38944528 |
| 13 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.28201480 |
| 14 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.27865030 |
| 15 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.14795612 |
| 16 | Focal adhesion_Homo sapiens_hsa04510 | 2.10691611 |
| 17 | Malaria_Homo sapiens_hsa05144 | 2.10667614 |
| 18 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.01744905 |
| 19 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.97027257 |
| 20 | Tuberculosis_Homo sapiens_hsa05152 | 1.94241233 |
| 21 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.93912129 |
| 22 | Carbon metabolism_Homo sapiens_hsa01200 | 1.90740178 |
| 23 | Viral myocarditis_Homo sapiens_hsa05416 | 1.87583818 |
| 24 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.79636216 |
| 25 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.75694933 |
| 26 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.71053218 |
| 27 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.62944358 |
| 28 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.61184685 |
| 29 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.55379523 |
| 30 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.55193021 |
| 31 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.53591998 |
| 32 | Adherens junction_Homo sapiens_hsa04520 | 1.50186489 |
| 33 | Measles_Homo sapiens_hsa05162 | 1.42270044 |
| 34 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.40209977 |
| 35 | Insulin resistance_Homo sapiens_hsa04931 | 1.39102335 |
| 36 | Legionellosis_Homo sapiens_hsa05134 | 1.38731430 |
| 37 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.33615977 |
| 38 | Tight junction_Homo sapiens_hsa04530 | 1.29727055 |
| 39 | Amoebiasis_Homo sapiens_hsa05146 | 1.29311669 |
| 40 | Parkinsons disease_Homo sapiens_hsa05012 | 1.28617480 |
| 41 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.28246042 |
| 42 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.27033598 |
| 43 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.26263720 |
| 44 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.26247952 |
| 45 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.26032609 |
| 46 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.24684955 |
| 47 | Influenza A_Homo sapiens_hsa05164 | 1.22533543 |
| 48 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.22502188 |
| 49 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.21287295 |
| 50 | Phagosome_Homo sapiens_hsa04145 | 1.20865607 |
| 51 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.20015363 |
| 52 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.19560686 |
| 53 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.18969620 |
| 54 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.14612162 |
| 55 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.13600796 |
| 56 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.13433248 |
| 57 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.13361871 |
| 58 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.12728437 |
| 59 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.10039083 |
| 60 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.08685104 |
| 61 | Pertussis_Homo sapiens_hsa05133 | 1.06664928 |
| 62 | Allograft rejection_Homo sapiens_hsa05330 | 1.06645623 |
| 63 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.05927345 |
| 64 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.04553705 |
| 65 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.02229186 |
| 66 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.02038754 |
| 67 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.00642802 |
| 68 | Hepatitis B_Homo sapiens_hsa05161 | 1.00501423 |
| 69 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.99861512 |
| 70 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.99307136 |
| 71 | Hepatitis C_Homo sapiens_hsa05160 | 0.98925691 |
| 72 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.98775828 |
| 73 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.97587231 |
| 74 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.97169056 |
| 75 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.95434997 |
| 76 | Shigellosis_Homo sapiens_hsa05131 | 0.95056162 |
| 77 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.94189371 |
| 78 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.93941609 |
| 79 | Other glycan degradation_Homo sapiens_hsa00511 | 0.93859755 |
| 80 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.92518316 |
| 81 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.92475158 |
| 82 | Alzheimers disease_Homo sapiens_hsa05010 | 0.91415679 |
| 83 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.91105507 |
| 84 | Lysine degradation_Homo sapiens_hsa00310 | 0.89728693 |
| 85 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.89461999 |
| 86 | Endocytosis_Homo sapiens_hsa04144 | 0.89390223 |
| 87 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.89055135 |
| 88 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.88887622 |
| 89 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.87648642 |
| 90 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.85267237 |
| 91 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.84433718 |
| 92 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.83810472 |
| 93 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.83545210 |
| 94 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.82991220 |
| 95 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.82525923 |
| 96 | Endometrial cancer_Homo sapiens_hsa05213 | 0.82048612 |
| 97 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.80610689 |
| 98 | Apoptosis_Homo sapiens_hsa04210 | 0.79675856 |
| 99 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.78910085 |
| 100 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.78467489 |
| 101 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.76684138 |
| 102 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.75233083 |
| 103 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.74870249 |
| 104 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.74037322 |
| 105 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.73405983 |
| 106 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.73342738 |
| 107 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.72522443 |
| 108 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.72205107 |
| 109 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.69289162 |
| 110 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.68424564 |
| 111 | Huntingtons disease_Homo sapiens_hsa05016 | 0.67495548 |
| 112 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.67387404 |
| 113 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.65794056 |
| 114 | Glioma_Homo sapiens_hsa05214 | 0.65415834 |
| 115 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.65265245 |
| 116 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.64128605 |
| 117 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.63884747 |
| 118 | Platelet activation_Homo sapiens_hsa04611 | 0.62777195 |
| 119 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.62292437 |
| 120 | Long-term potentiation_Homo sapiens_hsa04720 | 0.61705911 |
| 121 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.61575423 |
| 122 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.61367791 |
| 123 | Bladder cancer_Homo sapiens_hsa05219 | 0.61282928 |
| 124 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.60265357 |
| 125 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.59786299 |
| 126 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.58758143 |
| 127 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.56484418 |
| 128 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.56160885 |
| 129 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.55317372 |
| 130 | Bile secretion_Homo sapiens_hsa04976 | 0.54718817 |
| 131 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.54226886 |
| 132 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.54136919 |
| 133 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.52782396 |
| 134 | Colorectal cancer_Homo sapiens_hsa05210 | 0.51467204 |
| 135 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.50936137 |
| 136 | Lysosome_Homo sapiens_hsa04142 | 0.50456932 |
| 137 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.46493254 |
| 138 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.46099343 |
| 139 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.46037914 |
| 140 | Gap junction_Homo sapiens_hsa04540 | 0.45663357 |
| 141 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.45400165 |
| 142 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.44967004 |
| 143 | Renin secretion_Homo sapiens_hsa04924 | 0.43274938 |
| 144 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.41013130 |
| 145 | Pathways in cancer_Homo sapiens_hsa05200 | 0.40619655 |
| 146 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.40083837 |
| 147 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.39995405 |
| 148 | Melanoma_Homo sapiens_hsa05218 | 0.39703007 |
| 149 | Galactose metabolism_Homo sapiens_hsa00052 | 0.39600184 |
| 150 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.39164555 |
| 151 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.37894815 |
| 152 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.37357287 |
| 153 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.37113292 |
| 154 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.36095168 |
| 155 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.34054812 |
| 156 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.33766994 |
| 157 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.33286006 |
| 158 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.33003606 |
| 159 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.32523197 |
| 160 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.31632898 |
| 161 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.29899660 |
| 162 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.28434931 |
| 163 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.28054674 |
| 164 | Melanogenesis_Homo sapiens_hsa04916 | 0.27008376 |
| 165 | Salmonella infection_Homo sapiens_hsa05132 | 0.25541758 |
| 166 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.25478238 |
| 167 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.25051900 |

